Notify me when North Peak Capital Management, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AGL | agilon health, inc. | Common stock, par value $0.01 | 9.5% | $40,594,316 | +$18,411,536 | 39,411,957 | +83% | North Peak Capital Management, LLC | 30 Sep 2025 |
| HAE | Haemonetics Corporation | Common stock, $.01 par value per share | 5.1% | $154,129,585 | 2,370,495 | North Peak Capital Management, LLC | 24 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|